Follow-Up Studies of Lithium and Thyroid Function in Manic-Depressive Illness
Abstract
In an earlier study the authors reported that six out of 19 manic-depressive patients treated with lithium showed evidence of goiter, suggesting that lithium may have goitrogenic properties. They now report the finding of a similar incidence of goiter among 13 patients treated with imipramine. They conclude that three explanations are possible: the incidence of goiter among the general population might be equally high if EAI scanning instead of palpation were used routinely; the incidence of goiter detected among the two groups of patients studied may be a result of various drug treatments, periodic hospitalizations, and dietary insufficiencies; or it may be related to some characteristic of manic-depressive disease.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).